| Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial HW Rodbard, I Lingvay, J Reed, R De La Rosa, L Rose, D Sugimoto, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2291-2301, 2018 | 298 | 2018 |
| Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy T Vilsbøll, SC Bain, LA Leiter, I Lingvay, D Matthews, R Simó, IC Helmark, ... Diabetes, Obesity and Metabolism 20 (4), 889-897, 2018 | 225 | 2018 |
| Evaluation of point‐of‐care haemoglobin measuring devices: a comparison of Radical‐7™ pulse co‐oximetry, HemoCue® and laboratory haemoglobin … VA Skelton, N Wijayasinghe, S Sharafudeen, A Sange, NS Parry, ... Anaesthesia 68 (1), 40-45, 2013 | 72 | 2013 |
| Ultrasound guided intercostobrachial nerve blockade in patients with persistent pain after breast cancer surgery: a pilot study N Wijayasinghe, HM Duriaud, H Kehlet, KG Anderson Pain Physician 19 (2), E309, 2016 | 67 | 2016 |
| Neural blockade for persistent pain after breast cancer surgery N Wijayasinghe, KG Andersen, H Kehlet Regional Anesthesia & Pain Medicine 39 (4), 272-278, 2014 | 54 | 2014 |
| Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: pooled analysis of the SUSTAIN 1‐5 trials M Warren, L Chaykin, D Trachtenbarg, G Nayak, N Wijayasinghe, ... Diabetes, Obesity and Metabolism 20 (9), 2291-2297, 2018 | 47 | 2018 |
| Analgesic and sensory effects of the pecs local anesthetic block in patients with persistent pain after breast cancer surgery: a pilot study N Wijayasinghe, KG Andersen, H Kehlet Pain Practice 17 (2), 185-191, 2017 | 34 | 2017 |
| The role of peripheral afferents in persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial of ultrasound-guided tender … N Wijayasinghe, TK Ringsted, JM Bischoff, H Kehlet, MU Werner British journal of anaesthesia 116 (6), 829-837, 2016 | 23 | 2016 |
| Efficacy and safety of semaglutide once-weekly vs. placebo as add-on to basal insulin alone or in combination with metformin in subjects with type 2 diabetes (SUSTAIN 5) R Conway, H Rodbard, I Lingvay, J Reed, RD Rosa, L Rose, D Sugimoto, ... Canadian Journal of Diabetes 40 (5), S41-S42, 2016 | 5 | 2016 |
| Ultrasound Guided Intercostobrachial Nerve Blockade in Patients with Persistent Pain after Breast Cancer Surgery: A Pilot Study Prospective Study (vol 19, pg E309, 2016) N Wijayasinghe, HM Duriaud, H Kehlet, KG Anderson Pain Physician 19 (3), 203-203, 2016 | 5 | 2016 |
| 998-P: Efficacy and safety of semaglutide by baseline BMI in SUSTAIN 1-5 and 7 A Viljoen, JP Frias, T Gondolf, O Hansen, N Wijayasinghe, J Unger Diabetes 68 (Supplement_1), 2019 | 2 | 2019 |
| Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1-5 trials M Warren, L Chaykin, D Trachtenbarg, G Nayak, N Wijayasinghe, ... DIABETOLOGIA 60, S378-S379, 2017 | 2 | 2017 |
| Case report: A comatose patient with pregabalin overdose successfully treated with continuous renal replacement therapy VT Nielsen, N Wijayasinghe, LCG Høgberg, S Bøgevig Frontiers in Medicine 10, 1125653, 2023 | | 2023 |
| Efficacy and safety of semaglutide by baseline BMI in SUSTAIN 1-5 and 7 A Viljoen, JP Frias, T Gondolf, O Hansen, N Wijayasinghe, J Unger DIABETES 68, 2019 | | 2019 |
| Semaglutid ermöglichte eine überlegene Gewichtsabnahme über die klinischen Studien SUSTAIN 1–5 hinweg I Lingvay, M Marre, K Uusinarkaus, V Woo, HF Thomsen, N Wijayasinghe, ... Diabetologie und Stoffwechsel 13 (S 01), P 148, 2018 | | 2018 |
| Semaglutide provides superior body weight reduction across SUSTAIN 1-5 clinical trials MJ Davies, J Luedemann, M Marre, K Uusinarkaus, V Woo, HF Thomsen, ... DIABETIC MEDICINE 35, 82-82, 2018 | | 2018 |
| Treatment with semaglutide provides superior body weight reduction vs comparators in subjects with type 2 diabetes across the SUSTAIN 1-5 trials I Lingvay, J Luedemann, M Marre, K Uusinarkaus, V Woo, HF Thomsen, ... DIABETOLOGIA 60, S377-S378, 2017 | | 2017 |
| Méta-analyse des études SUSTAIN 1-5: Perte de poids sous semaglutide dans le diabète de type 2 B Cariou, I Lingvay, J Lüdemann, M Marre, K Uusinarkaus, V Woo, ... Annales d'Endocrinologie 78 (4), 398-399, 2017 | | 2017 |
| Semaglutide Provides Superior Body Weight Reduction across SUSTAIN 1-5 Clinical Trials I Lingvay, J Luedemann, M Marre, K Uusinarkaus, V Woo, HF Thomsen, ... DIABETES 66, A64-A64, 2017 | | 2017 |
| Étude SUSTAIN 5: efficacité et tolérance du semaglutide une fois par semaine versus placebo en add-on à l’insuline basale seule ou en combinaison à la metformine chez des … P Darmon, A Bouzidi, H Comcast, ILI Lingvay, JC Reed, R De la Rosa, ... Diabetes & Metabolism 43 (2), A108, 2017 | | 2017 |
